Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2

Dejnirattisai W. et al, (2021)

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

Wouters OJ. et al, (2021), Lancet, 397, 1023 - 1034

A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice.

Silva-Cayetano A. et al, (2021), Med (N Y), 2, 243 - 262.e8

Risdiplam in Type 1 Spinal Muscular Atrophy.

Baranello G. et al, (2021), N Engl J Med, 384, 915 - 923

White matter hyperintensities classified according to intensity and spatial location reveal specific associations with cognitive performance

Melazzini L. et al, (2021), NeuroImage: Clinical

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Voysey M. et al, (2021), Lancet, 397, 881 - 891

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy.

Winkelsas AM. et al, (2021), Mol Ther Nucleic Acids, 23, 731 - 742

In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control

Ansari MA. et al, (2021), Wellcome Open Research, 6, 47 - 47

ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge.

Fischer RJ. et al, (2021), NPJ Vaccines, 6

Assessing COVID-19 cohorting strategies in a UK district general hospital during the first wave of COVID-19.

Davies T. et al, (2021), Clin Med (Lond), 21, 40 - 41

Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Uhlig HH. et al, (2021), J Pediatr Gastroenterol Nutr, 72, 456 - 473

Deciphering the transcriptomic heterogeneity of duodenal coeliac disease biopsies

Wolf J. et al, (2021), International Journal of Molecular Sciences, 22, 1 - 29

Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.

Adler H. et al, (2021), Am J Respir Crit Care Med, 203, 604 - 613

Hippocampal GABA-A alpha 5 receptor subunits are downregulated in the methylazoxymethanol model of schizophrenia

Kiemes A. et al, (2021), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 44, S5 - S6

Neonatal amygdala volumes and the development of self-regulation from early infancy to toddlerhood.

Nolvi S. et al, (2021), Neuropsychology, 35, 285 - 299

Preterm birth phenotypes have differential morbidity, growth and neurodevelopment at age 2: the INTERBIO-21st Newborn

KENNEDY S. et al, (2021), JAMA Pediatrics

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom.

Versteegen P. et al, (2021), EBioMedicine, 65

Strategies for typhoid conjugate vaccines in endemic nations – Authors' reply

Pitzer VE. et al, (2021), The Lancet Infectious Diseases, 21, 321 - 322

Successful incorporation of a genetic risk prediction research platform into routine newborn screening

Bendor-Samuel OM. et al, (2021)

Travel restrictions as a disease control measure: Lessons from yellow fever.

Vanderslott S. and Marks T., (2021), Glob Public Health, 16, 340 - 353

Load More

«
...
56
57
58
59
60
61
62
...
»

Include forthcoming?